Elimination of Antigen-Presenting Cells and Autoreactive T Cells by Fas Contributes to Prevention of Autoimmunity

Immunity

Volumn 26, Issue 5, 2007, Pages 629-641

  Stranges, Peter B ^a,b   Watson, Jessica ^a   Cooper, Cristie J ^c   Choisy Rossi, Caroline Morgane ^a   Stonebraker, Austin C ^a   Beighton, Ryan A ^c   Hartig, Heather ^a   Sundberg, John P ^a   Servick, Stein ^a   Kaufmann, Gunnar ^a   Fink, Pamela J ^c   Chervonsky, Alexander V ^a,b  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CELLCYCLE; CELLIMMUNO; MOLIMMUNO

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, CD11C; ANTIGENS, CD95; AUTOIMMUNITY; B-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; GENE DELETION; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 34248577055     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.03.016     Document Type: Article

References (43)

1. Arai H., Chan S.Y., Bishop D.K., and Nabel G.J. Inhibition of the alloantibody response by CD95 ligand. Nat. Med. 3 (1997) 843-848
2. Bevan M.J., and Fink P.J. The CD8 response on autopilot. Nat. Immunol. 2 (2001) 381-382
3. Brocker T., Riedinger M., and Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185 (1997) 541-550
4. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., Ware C.F., et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373 (1995) 441-444
5. Chen M., Wang Y.H., Wang Y., Huang L., Sandoval H., Liu Y.J., and Wang J. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311 (2006) 1160-1164
6. Choi E.Y., Christianson G.J., Yoshimura Y., Sproule T.J., Jung N., Joyce S., and Roopenian D.C. Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. Immunity 17 (2002) 593-603
7. Crispe I.N. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1 (1994) 347-349
8. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., and Mescher M.F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174 (2005) 4465-4469
9. Custer R.P., Bosma G.C., and Bosma M.J. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am. J. Pathol. 120 (1985) 464-477
10. Dhein J., Walczak H., Baumler C., Debatin K.M., and Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373 (1995) 438-441
11. Fields M.L., Sokol C.L., Eaton-Bassiri A., Seo S., Madaio M.P., and Erikson J. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J. Immunol. 167 (2001) 2370-2378
12. Fisher G.H., Rosenberg F.J., Straus S.E., Dale J.K., Middleton L.A., Lin A.Y., Strober W., Lenardo M.J., and Puck J.M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81 (1995) 935-946
13. Foulds K.E., Zenewicz L.A., Shedlock D.J., Jiang J., Troy A.E., and Shen H. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168 (2002) 1528-1532
14. Fukuyama H., Adachi M., Suematsu S., Miwa K., Suda T., Yoshida N., and Nagata S. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice. J. Immunol. 160 (1998) 3805-3811
15. Gu H., Zou Y.R., and Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73 (1993) 1155-1164
16. Hao Z., Hampel B., Yagita H., and Rajewsky K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J. Exp. Med. 199 (2004) 1355-1365
17. Hennet T., Hagen F.K., Tabak L.A., and Marth J.D. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA 92 (1995) 12070-12074
18. Hildeman D.A., Zhu Y., Mitchell T.C., Bouillet P., Strasser A., Kappler J., and Marrack P. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16 (2002) 759-767
19. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
21. Ingulli E., Mondino A., Khoruts A., and Jenkins M.K. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J. Exp. Med. 185 (1997) 2133-2141
22. Jacob J., and Baltimore D. Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399 (1999) 593-597
23. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (1989) 1-13
24. Karray S., Kress C., Cuvellier S., Hue-Beauvais C., Damotte D., Babinet C., and Levi-Strauss M. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J. Immunol. 172 (2004) 2118-2125
25. Lynch D.H., Watson M.L., Alderson M.R., Baum P.R., Miller R.E., Tough T., Gibson M., Davis-Smith T., Smith C.A., Hunter K., et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1 (1994) 131-136
26. Medema J.P., Schuurhuis D.H., Rea D., van Tongeren J., de Jong J., Bres S.A., Laban S., Toes R.E., Toebes M., Schumacher T.N., et al. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194 (2001) 657-667
27. Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., and Pamer E.G. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165 (2000) 6833-6839
28. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
29. Obst R., van Santen H.M., Mathis D., and Benoist C. Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J. Exp. Med. 201 (2005) 1555-1565
30. Park S.M., Schickel R., and Peter M.E. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr. Opin. Cell Biol. 17 (2005) 610-616
31. Rickert R.C., Roes J., and Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25 (1997) 1317-1318
32. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I.A., Debatin K.M., Fischer A., and de Villartay J.P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 (1995) 1347-1349
33. Shlomchik M.J., Madaio M.P., Ni D., Trounstein M., and Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180 (1994) 1295-1306
34. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G., and Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286 (1999) 1957-1959
35. Storni T., Ruedl C., Renner W.A., and Bachmann M.F. Innate immunity together with duration of antigen persistence regulate effector T cell induction. J. Immunol. 171 (2003) 795-801
36. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., and Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76 (1994) 969-976
37. Theofilopoulos A.N., and Dixon F.J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37 (1985) 269-390
38. Warren R.W., Caster S.A., Roths J.B., Murphy E.D., and Pisetsky D.S. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin. Immunol. Immunopathol. 31 (1984) 65-77
39. Warren R.W., Roths J.B., Murphy E.D., and Pisetsky D.S. Mechanisms of polyclonal B-cell activation in autoimmune B6-lpr/lpr mice. Cell. Immunol. 84 (1984) 22-31
40. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314-317
41. Wong P., and Pamer E.G. Feedback regulation of pathogen-specific T cell priming. Immunity 18 (2003) 499-511
42. Wu J., Wilson J., He J., Xiang L., Schur P.H., and Mountz J.D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98 (1996) 1107-1113
43. Yang J., Huck S.P., McHugh R.S., Hermans I.F., and Ronchese F. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA 103 (2006) 147-152